Net income · 2019–2025
Keros Therapeutics net income
$87.0M+$274M · FY2025
Keros Therapeutics (KROS) reported $87.0M in net income for fiscal 2025, +$274M from the year before.
| Fiscal year | Net income | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $87.0M | +$274M | Open → |
| FY20242024-12-31 | −$187M | −$34.4M | Open → |
| FY20232023-12-31 | −$153M | −$48.3M | Open → |
| FY20222022-12-31 | −$105M | −$45.9M | Open → |
| FY20212021-12-31 | −$58.7M | −$13.4M | Open → |
| FY20202020-12-31 | −$45.4M | −$33.0M | Open → |
| FY20192019-12-31 | −$12.3M | — | Open → |
Net income — Net income is profit after tax and all expenses, as reported in the annual filing. Companies reporting a loss are excluded from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Net income at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Keros Therapeutics net income |url=https://companiesranked.com/en/company/keros-therapeutics/net-income |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Keros Therapeutics net income. CompaniesRanked. https://companiesranked.com/en/company/keros-therapeutics/net-incomeBibTeX
@misc{companiesranked-en-company-keros-therapeutics-net-income-2026,
author = {{CompaniesRanked}},
title = {{Keros Therapeutics net income}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/keros-therapeutics/net-income}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.